Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 252

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 252
---
-----------------|----:|:----|:-------|-----:|:--|:----|:-----------|-----:|:--|:----|:---------|:-----------|:----|:----------------------|
| CervoMed Inc.                      |     | NasdaqCM:CRVO         |     | $         |   16.98 |     | $              | 140.1 |     | $          | 95.1 |     | $                | 9.7 |     | $      |  0.0 |   |     | ($         |  9.9 | ) |     |          | Healthcare |     | Biotechnology         |
| enVVeno Medical Corporation        |     | NasdaqCM:NVNO         |     | $         |    5.25 |     | $              |  69.9 |     | $          | 32.1 |     | $                | 0.0 |     | ($     | 22.4 | ) |     | ($         | 22.6 | ) |     |          | Healthcare |     | Health Care Equipment |
|                                    |     |                       |     |           | AVERAGE |     | $              | 105.0 |     |            |      |     |                  |     |     |        |      |   |     |            |      |   |     |          |            |     |                       |

| Aegeria    |     | $ | 101.7 |
| Reflow RVO |     | $ |  19.1 |
| Aureva     |     | $ | 105.0 |
| COMBINED   |     | $ | 225.9 |

Source: S&P Capital IQ (as of September 12th, 2024)

Discounted Cash Flow Analysis

The Discounted Cash Flow Analysis (the “DCF Analysis”) approach is a valuation technique that provides an estimation of the value of a business based on the cash flows that a business can be expected to generate. The DCF Analysis begins with an estimation of the annual cash flows the subject business is expected to generate over a 10-year projection period. The estimated cash flows for each of the years in the projection period are then converted to their present value equivalents using a rate of return appropriate for the risk of achieving the projected cash flows. The present value of the estimated cash flows are then added to the present value equivalent of the residual/terminal